Offer - Urjas Oil for just ₹ 1 X
Metosartan LN 25 Tablet ER (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Metosartan LN 25 Tablet ER (10) safe for pregnant women?
Metosartan LN Tablet has many dangerous side effects in pregnant women. If you are pregnant, do not consume Metosartan LN Tablet without medical advice.
Is the use of Metosartan LN 25 Tablet ER (10) safe during breastfeeding?
Metosartan LN Tablet has been seen to have minimal side effects on breastfeeding women.
What is the effect of Metosartan LN 25 Tablet ER (10) on the Kidneys?
Metosartan LN Tablet does not damage the kidneys.
What is the effect of Metosartan LN 25 Tablet ER (10) on the Liver?
Very few cases of side effects of Metosartan LN Tablet on the liver have been reported.
What is the effect of Metosartan LN 25 Tablet ER (10) on the Heart?
Very few cases of side effects of Metosartan LN Tablet on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Metosartan LN 25 Tablet ER (10) unless your doctor advises you to do so -
Is this Metosartan LN 25 Tablet ER (10) habit forming or addictive?
Forming a habit of Metosartan LN 25 Tablet ER (10) has not been reported.
Interaction between Food and Metosartan LN 25 Tablet ER (10)
Metosartan LN 25 Tablet ER (10) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Metosartan LN 25 Tablet ER (10)
Consumption of alcohol and Metosartan LN 25 Tablet ER (10) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)